Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Type II Non-Obese Diabetic”

29 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 29 results

Large-scale testing (Phase 3)Ended earlyNCT00449605
What this trial is testing

A Glycemic Control Evaluation of Glimepiride Versus Rimonabant on Top of Metformin in Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
Sanofi 508
Not applicableUnknownNCT02091323
What this trial is testing

Effect of Laparoscopic Roux-en-Y Gastric Bypass Surgery on Non-severe Obesity With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus, Non-Insulin-Dependent
Guangzhou General Hospital of Guangzhou Military Command 200
Not applicableStudy completedNCT01141192
What this trial is testing

The Effect of Vitamin D Supplementation on Glucose Metabolism in Non-Diabetic African American Adults

Who this might be right for
Type 2 Diabetes
Augusta University 48
Not applicableStudy completedNCT00704314
What this trial is testing

Does Simvastatin Affect Insulin Sensitivity in Dyslipidemic Type 2 Diabetic Patients?

Who this might be right for
HypercholesterolemiaDiabetesCardiovascular Disease
Medical University of Vienna 20
Testing effectiveness (Phase 2)Study completedNCT00478322
What this trial is testing

Pharmacodynamic Study of the Effect of INCB013739 on Insulin Sensitivity in Obese, Type 2 Diabetic Subjects

Who this might be right for
Diabetes Mellitus, Type 2Obesity
Incyte Corporation 24
Large-scale testing (Phase 3)Study completedNCT07820111
What this trial is testing

Comparative Study of Different Weekly GLP-1 Receptor Agonists Among Diabetic and Non-Diabetic Patients: Clinical Trial

Who this might be right for
Obese DiabeticsObese Non Diabetic
Zagazig University 159
Testing effectiveness (Phase 2)Study completedNCT00042601
What this trial is testing

Evaluation of the Effect of Pramlintide on Satiety and Food Intake

Who this might be right for
Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2
AstraZeneca 51
Early research (Phase 1)Study completedNCT04407234
What this trial is testing

Measure Stomach Emptying in Overweight Non-diabetic and Diabetic Participants Using Tirzepatide

Who this might be right for
OverweightObesityDiabetes Mellitus, Type 2
Eli Lilly and Company 36
Post-approval studies (Phase 4)Study completedNCT00339833
What this trial is testing

The Effects of Anti-Inflammatory Treatment on Insulin Resistance in Healthy Volunteers

Who this might be right for
Type 2 DiabetesDiabetes
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 54
Large-scale testing (Phase 3)Study completedNCT00976937
What this trial is testing

24-week Study Comparing Lixisenatide to Sitagliptin as add-on to Metformin in Obese Type 2 Diabetic Patients Younger Than 50 Years

Who this might be right for
Type 2 Diabetes Mellitus
Sanofi 319
Testing effectiveness (Phase 2)Study completedNCT04617275
What this trial is testing

A 12-WEEK TITRATE STUDY TO EVALUATE SAFETY, TOLERABILITY AND PHARMACODYNAMICS OF PF-06882961 IN ADULTS WITH TYPE 2 DIABETES MELLITUS AND IN NON-DIABETIC ADULTS WITH OBESITY

Who this might be right for
DiabetesObesity
Pfizer 151
Not applicableStudy completedNCT00849342
What this trial is testing

Observational Study on Levemir® in Obese Diabetic Patients

Who this might be right for
DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Novo Nordisk A/S 580
Post-approval studies (Phase 4)Looking for participantsNCT07513168
What this trial is testing

Low-Dose Semaglutide for Weight Loss in Obese Non-Diabetic Pakistani Adults

Who this might be right for
ObesityWeight ReductionCardiometabolic Risk Factors
Asian Institute Of Medical Sciences 60
Testing effectiveness (Phase 2)Ended earlyNCT01842282
What this trial is testing

Amlexanox for Type 2 Diabetes and Obesity

Who this might be right for
Diabetes Mellitus Type 2Non Alcoholic Fatty Liver DiseaseObesity
University of Michigan 7
Testing effectiveness (Phase 2)Study completedNCT00156897
What this trial is testing

Efficacy and Safety of ATL-962 in Obese Diabetics

Who this might be right for
Non-Insulin-Dependent Diabetes MellitusObesity
Alizyme 600
Large-scale testing (Phase 3)Ended earlyNCT01644201
What this trial is testing

A Study Evaluating the Effects of a High Viscosity Non-starch Polysaccharide (PolyGlycopleX® - PGX®) on Glycemic Control, Cardiometabolic Risk Factors and Weight Loss in Overweight and Obese Type II Diabetics

Who this might be right for
Type II Diabetes MellitusObesity
InovoBiologic Inc. 100
Not applicableUnknownNCT04081064
What this trial is testing

Impact of Body Composition and Exercise on Clinical, Metabolic and Molecular Parameters in Type 2 Diabetics in Qatar

Who this might be right for
Type 2 Diabetes
Hamad Medical Corporation 60
Early research (Phase 1)Looking for participantsNCT07803809
What this trial is testing

Phase 1 Clinical Study of MWN105 Injection in Participants With Overweight or Obesity

Who this might be right for
Overweight , ObesityType 2 Diabetes Mellitus (T2DM)MASH - Metabolic Dysfunction-Associated Steatohepatitis
Shanghai Minwei Biotechnology Co., Ltd 36
Early research (Phase 1)Study completedNCT03414736
What this trial is testing

A Study on Safety and Tolerability of SAR425899 in Overweight to Obese Subjects and Type 2 Diabetes Mellitus Patients Not Requiring Anti-Diabetic Pharmacotherapy With an Optional 6-month Safety Extension Period

Who this might be right for
Type 2 Diabetes Mellitus
Sanofi 60
Not applicableUnknownNCT05908812
What this trial is testing

Relationship Between Glycemic Control and Irisin in Type 2 Diabetic Patients With Sarcopenic or Non-sarcopenic Obesity

Who this might be right for
SarcopeniaObesityDiabetes Mellitus, Type 2
Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari 120
Next Page